stay curious

Our Blog

Revolutionizing NMR Access: The Bruker BioSpin Connexus Platform

In the ever-evolving landscape of scientificresearch, access to cutting-edge technologies and expertise is pivotal forbreakthrough discoveries. Among the array of analytical techniques, NuclearMagnetic Resonance (NMR) stands out for its ability to provide detailedinsights into the structure, dynamics, and interactions of molecules. However,the challenge lies in accessing NMR instruments and specialized analyticalservices, particularly for researchers and institutions with limited resourcesor in-house expertise.Bruker BioSpin, a pioneering leader inanalytical magnetic resonance instrumentation, has introduced an innovativesolution: Connexus. Connexus serves as adigital bridge, connecting NMR scientists with laboratories equipped withstate-of-the-art instruments and expertise. Let's delve deeper into thesignificance of Connexus, its key features, and the benefits it offers to thescientific community.

May 15, 2024

Our insights...

Startup Spotlight

Pentabind: AI Enhanced Aptamers Redefining Drug Discovery

PentaBind, a biotech start-up from London, aims to drug the undruggable, targeting diseases that have long been considered beyond the reach of conventional drug discovery methods. Recognising that only 15% of the human proteome has been effectively targeted by existing drugs [2], they are pioneering a novel therapeutic approach that combines the high specificity of aptamers with the power of artificial intelligence (AI).

March 14, 2024

Startup Spotlight

BioMavericks: Pioneering Cancer Diagnosis with Next-Generation Sequencing Technology

In the quest to revolutionise cancer diagnosis, BioMavericks emerged amidst the COVID-19 crisis, recognizing a crucial gap in advanced sequencing methods for cancer detection. Their ground-breaking in vitro diagnostic tool, fuelled by proprietary biomarkers, with a sensitivity and specificity of over 97% promises exceptional accuracy in detecting prevalent cancers.

March 6, 2024